Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C14orf37 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | HEATR5B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | GEMIN6 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | REXO2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | ENY2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | UPF1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | SETD1A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | LRRC9 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | NR2C2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | PAIP2B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |